Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW274150 versus prednisolone versus placebo in rheumatoid arthritis
2005-001977-82Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing GW274150, Prednisolone and Placebo (3 arms). Primary endpoint: Synovial vascularity. Started Jul 2005; status: completed.
02
Drugs
GW274150prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-001977-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001977-82.